Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rampart Duo Clinical (RaDical) Study: An Exempt Minimal Risk Post-Market Evaluation of Clinical Outcomes

NCT03974711 is registered in ClinicalTrials.gov with Spineology, Inc as lead sponsor.

NCT NCT03974711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03974711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rampart Duo Clinical (RaDical) Study: An Exempt Minimal Risk Post-Market Evaluation of Clinical Outcomes
Lead sponsor
Spineology, Inc
Phase
Observational
Overall status
Completed
Start date
October 2, 2017
Completion date
October 3, 2022
Enrollment
197 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

lumbar degenerative disc disease